POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Efficacy of Sputnik M vaccine against coronavirus amounts to 93%

Christian Fernsby |
The effectiveness of the Sputnik M vaccine against the coronavirus infection for teenagers aged 12 to 17 amounts to about 93%, according to Russia’s federal anti-coronavirus internet portal.

Article continues below



Topics: SPUTNIK   

"To date, the efficacy of the Sputnik M vaccine amounts to about 93%," the statement said.

On November 24, the Russian Health Ministry certified the Sputnik M jab for the prevention of the coronavirus infection in teens aged 12-17. It consists of two components introduced with a 21-day interval.

The ministry noted that teenagers aged 12-15 can be inoculated only with the permission of parents or guardians, while those over 15 need to provide their own written informed voluntary consent.

The trials of the vaccine began in July 2021, Phase Three of the trials at twelve children medical facilities in Moscow is nearing completion. To date, scientists have determined that elevated body temperature is the only side effect of the jab.


What to read next

Hungary first in EU to approve Russian COVID-19 vaccine
Sputnik V provides strong defence against Omicron variant
Sputnik Light vaccine has high safety and 93.5% efficacy against COVID